Microisolated mouse osteoclasts express VIP-1 and PACAP receptors

被引:109
作者
Ransjö, M [1 ]
Lie, A
Mukohyama, H
Lundberg, P
Lerner, UH
机构
[1] Umea Univ, Dept Oral Cell Biol, S-90187 Umea, Sweden
[2] Umea Univ, Dept Orthodont, Umea, Sweden
[3] Tokyo Med & Dent Univ, Grad Sch, Div Maxillofacial Neck Reconstruct, Dept Maxillofacial Prosthet Maxillofacial Reconst, Tokyo, Japan
[4] Natl Inst Working Life, Ctr Musculoskeletal Res, Umea, Sweden
关键词
bone; osteoclasts; neuropeptides; vasoactive intestinal peptide; microisolation;
D O I
10.1006/bbrc.2000.3151
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Skeletal tissue contains a network of nerve fibers expressing several neuropeptides, including vasoactive intestinal peptide (VIP) and the related peptide pituitary adenylate cyclase activating peptide (PACAP). These peptides have been demonstrated to regulate osteoclast formation and osteoclast activity. Using atomic force microscopy and by analysing changes of the intracellular calcium concentrations, we have recently demonstrated that multinucleated rat osteoclasts have cell membrane binding sites recognising VIP and PACAP. In the present study, we have further studied the expression of VIP receptor subtypes in mouse bone marrow cultures and isolated osteoclasts. A micromanipulation technique was used to isolate pure populations of osteoclasts formed in PTH-stimulated mouse bone marrow cultures. By reverse transcriptase polymerase chain reaction (RT-PCR), we studied the expression of mRNA for VIP-1, VIP-2, and PACAP receptors. The purity of the microisolated osteoclasts was determined by studying the expression of specific mRNA associated with the phenotypic trait of osteoclasts or osteoblasts/stromal cells. In this study, we show that mouse osteoclasts express VIP-1 and PACAP, but not VIP-2, receptor mRNA (C) 2000 Academic Press.
引用
收藏
页码:400 / 404
页数:5
相关论文
共 24 条
[1]
EXTRACTION AND QUANTITATION OF NEUROPEPTIDES IN BONE BY RADIOIMMUNOASSAY [J].
AHMED, M ;
SRINIVASAN, GR ;
THEODORSSON, E ;
BJURHOLM, A ;
KREICBERGS, A .
REGULATORY PEPTIDES, 1994, 51 (03) :179-188
[2]
NEUROPEPTIDE Y-IMMUNOREACTIVE, TYROSINE HYDROXYLASE-IMMUNOREACTIVE AND VASOACTIVE INTESTINAL POLYPEPTIDE-IMMUNOREACTIVE NERVES IN BONE AND SURROUNDING TISSUES [J].
BJURHOLM, A ;
KREICBERGS, A ;
TERENIUS, L ;
GOLDSTEIN, M ;
SCHULTZBERG, M .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1988, 25 (2-3) :119-125
[3]
BJURHOLM A, 1988, THESIS U STOCKHOLM U
[4]
Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells [J].
Cai, YQ ;
Xin, XN ;
Shim, GJ ;
Mokuno, Y ;
Uehara, H ;
Yamada, T ;
Agui, T ;
Matsumoto, K .
ENDOCRINOLOGY, 1997, 138 (06) :2515-2520
[5]
Osteoclasts from human giant cell tumors of bone lack estrogen receptors [J].
Collier, FM ;
Huang, WH ;
Holloway, WR ;
Hodge, JM ;
Gillespie, MT ;
Daniels, LL ;
Zheng, MH ;
Nicholson, GC .
ENDOCRINOLOGY, 1998, 139 (03) :1258-1267
[6]
DISTRIBUTION OF CGRP-IMMUNOREACTIVE, VIP-IMMUNOREACTIVE, D-BETA-H-IMMUNOREACTIVE, SP-IMMUNOREACTIVE, AND NPY-IMMUNOREACTIVE NERVES IN THE PERIOSTEUM OF THE RAT [J].
HILL, EL ;
ELDE, R .
CELL AND TISSUE RESEARCH, 1991, 264 (03) :469-480
[7]
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [J].
Hofbauer, LC ;
Khosla, S ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :2-12
[8]
VASOACTIVE INTESTINAL PEPTIDE STIMULATES BONE-RESORPTION VIA A CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-DEPENDENT MECHANISM [J].
HOHMANN, EL ;
LEVINE, L ;
TASHJIAN, AH .
ENDOCRINOLOGY, 1983, 112 (04) :1233-1239
[9]
INNERVATION OF PERIOSTEUM AND BONE BY SYMPATHETIC VASOACTIVE-INTESTINAL-PEPTIDE CONTAINING NERVE-FIBERS [J].
HOHMANN, EL ;
ELDE, RP ;
RYSAVY, JA ;
EINZIG, S ;
GEBHARD, RL .
SCIENCE, 1986, 232 (4752) :868-871
[10]
Neuropeptides and the puzzle of bone remodeling - State of the art [J].
Konttinen, YT ;
Imai, S ;
Suda, A .
ACTA ORTHOPAEDICA SCANDINAVICA, 1996, 67 (06) :632-639